Efficacy News and Research

RSS
Mogrify solidifies IP position surrounding core technology and expands platform algorithm to enhance cell conversion

Mogrify solidifies IP position surrounding core technology and expands platform algorithm to enhance cell conversion

Additional data demonstrates positive results of pridopidine drug on Total Functional Capacity

Additional data demonstrates positive results of pridopidine drug on Total Functional Capacity

NET study: New theranostic approach effective in reducing tumor volume and extending lifespan

NET study: New theranostic approach effective in reducing tumor volume and extending lifespan

New screening platform can be used to discover more effective drugs for type 1 diabetes

New screening platform can be used to discover more effective drugs for type 1 diabetes

Researchers focus on preventing infections caused by carbapenemase-producing bacteria

Researchers focus on preventing infections caused by carbapenemase-producing bacteria

Traditional herbal medicine Respiratory Detox Shot (RDS) inhibits SARS-CoV, SARS-CoV-2 and Influenza A infection in vitro

Traditional herbal medicine Respiratory Detox Shot (RDS) inhibits SARS-CoV, SARS-CoV-2 and Influenza A infection in vitro

Azithromycin trial fails to provide evidence of benefit in COVID-19

Azithromycin trial fails to provide evidence of benefit in COVID-19

Copper gluconate supplementation could reduce SARS-CoV-2 infection in vitro

Copper gluconate supplementation could reduce SARS-CoV-2 infection in vitro

SARS-CoV-2 RNA can be reverse-transcribed to be part of chimeric viral-human genome

SARS-CoV-2 RNA can be reverse-transcribed to be part of chimeric viral-human genome

Methylene blue and light inactivates SARS-CoV-2 on N95 respirators and masks, study finds

Methylene blue and light inactivates SARS-CoV-2 on N95 respirators and masks, study finds

Researchers use aroma diffuser for assessing the fit of face masks

Researchers use aroma diffuser for assessing the fit of face masks

New data shows encouraging results for patients with neuro-degenerative blinding eye disease

New data shows encouraging results for patients with neuro-degenerative blinding eye disease

RedHill Biopharma announces promising preliminary results from opaganib study

RedHill Biopharma announces promising preliminary results from opaganib study

AI-based study of social media maps SARS-CoV-2 vaccine hesitancy across the US

AI-based study of social media maps SARS-CoV-2 vaccine hesitancy across the US

Research could lead to potential new treatments for mutant RAS-driven cancers

Research could lead to potential new treatments for mutant RAS-driven cancers

Mologic and the University of Liverpool collaborate to develop a rapid diagnostic test for common agricultural parasite

Mologic and the University of Liverpool collaborate to develop a rapid diagnostic test for common agricultural parasite

Not all masks protect the same: Research suggests no mask better than an old mask

Not all masks protect the same: Research suggests no mask better than an old mask

The effect of vaccination on the spread of COVID-19 disease

The effect of vaccination on the spread of COVID-19 disease

UHN gave first COVID-19 vaccine in Canada

UHN gave first COVID-19 vaccine in Canada

Emergence of resistant SARS-CoV-2 variant in immunocompromised patient following therapeutic antibody use

Emergence of resistant SARS-CoV-2 variant in immunocompromised patient following therapeutic antibody use

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.